Document Detail


Gore helex septal occluder for percutaneous closure of patent foramen ovale associated with atrial septal aneurysm: short- and mid-term clinical and echocardiographic outcomes.
MedLine Citation:
PMID:  23043034     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: To evaluate the short- and mid-term clinical and echocardiographic outcome of HELEX Septal Occluder (HSO) implantation in patients with patent foramen ovale (PFO) and atrial septal aneurysm (ASA).
BACKGROUND: Percutaneous closure of PFO and ASA with HSO device has not been systematically studied.
METHODS: We studied 90 patients with PFO and ASA with documented paradoxical embolic events. The procedural and clinical results of 30 consecutive patients treated with HSO were compared with those obtained in 30 consecutive patients treated with the Amplatzer PFO (APO) and with those of a further 30 consecutive patients treated with the Amplatzer Cribriform (AMF). Primary endpoint was the persistence of moderate to severe residual right-to-left shunting (rRLS) at 6-month follow-up. The incidence of death or recurrent embolic events (REE) at 1-year follow-up were also investigated.
RESULTS: The procedure was successfully completed in all patients. There was one HSO device embolization. Immediate moderate RLS was significantly higher in the HSO group compared to APO and AMF groups (20% vs 3% vs 0%, respectively; P=.008). The incidence of moderate rRLS decreased but was still significant at 6-month follow-up (17% in the HSO group vs 3% in the APO group; P=.02). At 1-year follow-up, moderate rRLS persisted only in the HSO group (7%). No deaths or REE were observed during hospitalization or at 1-year follow-up.
CONCLUSION: HSO device seems to be a second-line device as compared to Amplatzer occluders for the treatment of PFO and ASA.
Authors:
Carmine Musto; Alberta Cifarelli; Rosario Fiorilli; Francesco De Felice; Antonio Parma; Claudia Pandolfi; Pierpaolo Confessore; Leda Bernardi; Roberto Violini
Related Documents :
18303224 - Effect of laser spot diameter on the reproducibility of visual field analysis in diabet...
23543204 - A 17-year experience with mitral valve repair with artificial chordae in infants and ch...
23196934 - Durability of first art regimen and risk factors for modification, interruption or deat...
9730174 - Macular hole surgery using thrombin-activated fibrinogen and selective removal of the i...
16730534 - Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a cont...
22339794 - Short-term progression of wet amd and correlation with 1-year treatment results.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  24     ISSN:  1557-2501     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  510-4     Citation Subset:  IM    
Affiliation:
San Camillo Hospital Interventional cardiology, Via circonvallazione gianicolense, 87, 00152 Rome, Italy. cmusto@hotmail.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predictive value of renal resistive index in percutaneous renal interventions for atherosclerotic re...
Next Document:  Drug-Eluting Stenting of Saphenous Vein Graft Versus Native Coronary Artery Supplying the Same Myoca...